Search





Search





Markets
/
Stocks
/
adct
/

ADC Therapeutics SA

ADCT

Add to Watchlist

1.150USD

-0.045-3.69%

Close 07-24 16:00（ET）Quotes delayed by 15 min

146.27MMarket Cap

LossP/E TTM

ADC Therapeutics SA

1.150

-0.045-3.69%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

ADCT Cash Flow Statement

You can access the annual and quarterly cash flow statements of ADC Therapeutics SA to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q1

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2019Q4

FY2019Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

47.26%-29.71M

-42.43%-31.12M

-18.32%-29.63M

26.66%-24.09M

-27.76%-56.33M

30.92%-21.85M

31.71%-25.04M

---32.84M

-198.52%-44.09M

---31.63M

-1770.75%-36.67M

56.40%-14.77M

103.75%2.19M

8.62%-53.01M

38.56%-33.88M

-19.22%-61.63M

-32.11%-58.59M

---58.01M

---55.15M

-53.60%-51.69M

-37.56%-44.35M

---33.66M

---32.24M

Net income from continuing operations

14.60%-32.97M

79.14%-6.41M

6.83%-40.97M

-55.01%-56.65M

17.17%-38.60M

63.86%-30.73M

5.90%-43.97M

---36.54M

21.57%-46.61M

---85.03M

7.67%-46.73M

-256.68%-59.43M

29.27%-50.61M

11.29%-64.37M

67.67%-16.66M

38.53%-34.38M

-251.97%-71.55M

---72.57M

---51.53M

-58.51%-55.93M

35.14%-20.33M

---35.28M

---31.34M

Operating gains losses

----

-168.73%-545.00K

3.12%827.00K

708.59%6.78M

-4.98%801.00K

-6.38%793.00K

-9.38%802.00K

--838.00K

-46.75%843.00K

--847.00K

-33.91%885.00K

166.50%1.58M

103.50%1.34M

297.32%2.52M

2.77%594.00K

-7.33%759.00K

34.56%658.00K

--635.00K

--578.00K

64.79%819.00K

37.36%489.00K

--497.00K

--356.00K

Deferred tax

----

-100.00%0.00

100.00%0.00

--0.00

100.00%0.00

--42.85M

-231.07%-578.00K

78.01%-848.00K

--441.00K

---4.13M

---3.86M

---26.05M

----

Other non-cash items

-10.12%6.58M

-238.55%-13.67M

3.05%7.88M

17.02%8.23M

5.56%7.32M

-38.42%-4.04M

11.52%7.65M

--7.04M

786.14%6.93M

---2.92M

-77.22%6.86M

-186.93%-1.01M

10588.85%30.10M

103.24%212.00K

-20.55%-352.00K

-427.96%-1.52M

-392.86%-287.00K

---6.55M

---292.00K

-19.27%465.00K

126.70%98.00K

--576.00K

---367.00K

Change in working capital

87.51%-3.53M

-206.27%-11.17M

-92.64%629.00K

447.32%15.74M

-208.11%-28.27M

37.73%10.51M

1944.71%8.54M

---4.53M

-127.29%-9.18M

--7.63M

90.05%-463.00K

2267.31%33.62M

66.41%-4.65M

1007.12%16.47M

-193.60%-1.55M

-196.78%-9.58M

-524.49%-13.85M

--1.49M

--1.66M

887.92%9.90M

-24.76%-2.22M

--1.00M

---1.78M

-Change in receivables

83.15%-1.93M

-266.63%-6.19M

360.03%3.27M

1648.28%5.58M

-673.68%-11.45M

192.87%3.71M

-146.55%-1.26M

--319.00K

-95.92%2.00M

---4.00M

211.53%2.70M

1310.88%48.90M

82.49%-2.42M

383.26%5.89M

--3.47M

---14.32M

---13.82M

---2.08M

--0.00

-100.00%0.00

100.00%0.00

--150.00K

---140.00K

-Change in inventory

58.40%1.49M

80.92%-442.00K

68.30%-279.00K

-139.21%-316.00K

422.22%940.00K

-332.76%-2.32M

74.71%-880.00K

--806.00K

202.86%180.00K

--995.00K

-86.74%-3.48M

50.70%-175.00K

-26714.29%-1.86M

-306.52%-3.93M

---355.00K

---2.06M

--7.00K

---966.00K

----

-Change in prepaid expenses

--2.01M

---215.00K

---1.60M

----

-Change in payables and accrued expense

----

--14.95M

----

-Change in other current assets

----

-100.00%0.00

107.32%100.00K

784.94%3.05M

650.07%3.86M

-44.88%576.00K

-203.96%-1.37M

---445.00K

-1374.55%-701.00K

--1.04M

139.72%1.31M

105.16%55.00K

-88.06%-3.31M

279.34%4.86M

-199.07%-1.06M

-636.41%-2.96M

-18.21%-1.76M

---2.71M

--1.07M

-65.82%552.00K

72.28%-1.49M

--1.61M

---5.37M

-Change in other current liabilities

12.39%2.20M

-12.21%-6.72M

6.92%2.23M

-8.76%2.12M

136.69%1.96M

-494.01%-5.99M

-24.85%2.08M

--2.33M

55.79%-5.34M

--1.52M

-49.40%2.77M

-13.35%-12.09M

-3.17%5.47M

136.47%9.88M

-100.04%-10.67M

250.75%8.02M

944.55%5.65M

--4.18M

---5.33M

-677.85%-5.32M

605.61%541.00K

--921.00K

---107.00K

Cash from non-recurring investing activities

Cash from operating activities

47.26%-29.71M

-42.43%-31.12M

-18.32%-29.63M

26.66%-24.09M

-27.76%-56.33M

30.92%-21.85M

31.71%-25.04M

---32.84M

-198.52%-44.09M

---31.63M

-1770.75%-36.67M

56.40%-14.77M

103.75%2.19M

8.62%-53.01M

38.56%-33.88M

-19.22%-61.63M

-32.11%-58.59M

---58.01M

---55.15M

-53.60%-51.69M

-37.56%-44.35M

---33.66M

---32.24M

Investing cash flow

Net cash from continuing investing activities

-87.88%32.00K

-832.22%-659.00K

-100.00%0.00

-50.28%264.00K

-72.48%90.00K

-67.32%216.00K

--30.00K

-47.74%531.00K

--327.00K

160.24%661.00K

-9.12%1.02M

-89.14%254.00K

-71.59%809.00K

70.17%1.12M

-31.14%533.00K

66.88%2.34M

--2.85M

--657.00K

298.97%774.00K

2880.85%1.40M

--194.00K

--47.00K

Capital expenditures

-87.88%32.00K

-100.00%0.00

-50.28%264.00K

-72.48%90.00K

-67.32%216.00K

--30.00K

-47.74%531.00K

--327.00K

160.24%661.00K

-9.12%1.02M

-89.14%254.00K

-71.59%809.00K

70.17%1.12M

-31.14%533.00K

66.88%2.34M

--2.85M

--657.00K

298.97%774.00K

2880.85%1.40M

--194.00K

--47.00K

Net cash flow from disposal of fixed assets

-87.88%32.00K

-832.22%-659.00K

-100.00%0.00

-50.28%264.00K

-72.48%90.00K

-67.32%216.00K

--30.00K

-46.69%531.00K

--327.00K

240.72%661.00K

334.93%996.00K

-86.19%194.00K

-94.73%50.00K

-65.14%229.00K

141.38%420.00K

250.37%1.41M

--948.00K

--657.00K

2.96%174.00K

928.21%401.00K

--169.00K

--39.00K

Net cash flow from intangible asset transactions

----

-97.75%20.00K

-93.57%60.00K

-60.05%759.00K

--889.00K

-81.17%113.00K

-6.70%933.00K

--1.90M

--0.00

2300.00%600.00K

12400.00%1.00M

--25.00K

--8.00K

Net cash flow from investment products

----

--659.00K

----

Net cash flow from other investing activities

--0.00

----

100.00%0.00

--0.00

--120.00K

---330.00K

-1463.16%-297.00K

----

--0.00

81.00%-19.00K

----

---100.00K

----

Cash from non-current investing activities

Net cash flow from investing activities

87.88%-32.00K

832.22%659.00K

100.00%0.00

50.28%-264.00K

72.48%-90.00K

67.32%-216.00K

---30.00K

47.74%-531.00K

---327.00K

-160.24%-661.00K

29.83%-1.02M

89.14%-254.00K

75.81%-689.00K

-120.40%-1.45M

-4.67%-830.00K

-66.88%-2.34M

---2.85M

---657.00K

-169.73%-793.00K

-2880.85%-1.40M

---294.00K

---47.00K

Financing cash flow

Cash flow from continuous financing activities

-315.13%-583.00K

5197.23%57.09M

77.47%-198.00K

-4.98%93.78M

-23.88%271.00K

-111900.00%-1.12M

-351.86%-879.00K

--98.70M

281.63%356.00K

---1.00K

-85.24%349.00K

24.03%-196.00K

-98.92%2.37M

-100.51%-252.00K

13.13%-258.00K

57.58%-1.22M

14.61%219.30M

--49.60M

---297.00K

-2125.58%-2.87M

66080.34%191.34M

---129.00K

---290.00K

Net cash flow from debt Issuance/repayment

----

--0.00

----

--0.00

100.00%0.00

24.03%-196.00K

-101.75%-3.83M

-100.51%-252.00K

14.00%-258.00K

-588.37%-1.48M

70299.36%219.02M

--49.37M

---300.00K

-26.47%-215.00K

-9.86%-312.00K

---170.00K

---284.00K

Net cash flow from common stock issuance/repurchase

---20.00K

--43.52M

60.90%-479.00K

-29.96%43.24M

----

-100.00%0.00

---1.23M

--61.73M

----

--773.00K

----

--6.19M

----

100.00%0.00

-100.00%0.00

----

-6709.76%-2.71M

3194350.00%191.66M

--41.00K

---6.00K

Proceeds from stock option exercised by employees

-24.35%205.00K

409.30%219.00K

-18.79%281.00K

-17.07%34.00K

-23.88%271.00K

105.56%43.00K

-0.86%346.00K

--41.00K

--356.00K

---774.00K

--349.00K

----

-100.00%0.00

385.19%262.00K

--282.00K

--231.00K

--3.00K

--54.00K

----

Proceeds from issuance of warrants

----

--14.61M

--0.00

37.47%50.76M

----

--0.00

--36.92M

----

Net cash flow from other financing activities

---768.00K

-8.68%-1.26M

--0.00

---250.00K

----

---1.16M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-315.13%-583.00K

5197.23%57.09M

77.47%-198.00K

-4.98%93.78M

-23.88%271.00K

-111900.00%-1.12M

-351.86%-879.00K

--98.70M

281.63%356.00K

---1.00K

-85.24%349.00K

24.03%-196.00K

-98.92%2.37M

-100.51%-252.00K

13.13%-258.00K

57.58%-1.22M

14.61%219.30M

--49.60M

---297.00K

-2125.58%-2.87M

66080.34%191.34M

---129.00K

---290.00K

Net cash flow

Beginning cash balance

4.17%261.34M

-14.41%234.74M

-11.85%264.56M

-16.90%194.70M

-9.95%250.87M

-11.64%274.27M

-13.64%300.12M

--234.28M

-14.66%278.60M

--310.41M

-7.77%347.51M

-30.03%326.44M

1.32%376.78M

12.46%430.87M

6.23%466.54M

7.24%530.19M

6.68%371.88M

--383.12M

--439.19M

230.68%494.42M

91.37%348.59M

--149.52M

--182.16M

Current period cash flow changes

46.00%-30.33M

213.65%26.60M

-15.38%-29.82M

6.11%69.86M

-26.75%-56.17M

26.42%-23.41M

30.34%-25.85M

--65.83M

-178.80%-44.31M

---31.81M

-1008.94%-37.10M

55.44%-15.89M

-97.42%4.08M

-381.37%-54.10M

36.39%-35.67M

-15.26%-63.65M

8.56%158.31M

---11.24M

---56.07M

-62.58%-55.22M

546.78%145.82M

---33.97M

---32.64M

Effect of exchange rate changes

-103.11%-5.00K

92.71%-25.00K

-97.94%6.00K

1258.33%163.00K

474.42%161.00K

-325.66%-343.00K

346.61%291.00K

--12.00K

-148.31%-43.00K

--152.00K

47.32%-118.00K

208.54%89.00K

-229.41%-224.00K

-1066.67%-145.00K

-373.33%-82.00K

-78.83%29.00K

-129.82%-68.00K

--15.00K

--30.00K

22.32%137.00K

456.25%228.00K

--112.00K

---64.00K

Ending cash balance

18.65%231.01M

4.17%261.34M

-14.41%234.74M

-11.85%264.56M

-16.90%194.70M

-9.95%250.87M

-11.64%274.27M

--300.12M

-24.56%234.28M

--278.60M

-18.50%310.41M

-27.93%310.55M

-28.17%380.86M

1.32%376.78M

12.46%430.87M

6.23%466.54M

7.24%530.19M

--371.88M

--383.12M

280.09%439.19M

230.68%494.42M

--115.55M

--149.52M

Free cash flow

47.45%-29.74M

-41.84%-31.12M

-17.30%-29.63M

26.73%-24.09M

-26.83%-56.60M

31.35%-21.94M

32.34%-25.26M

---32.88M

-182.68%-44.63M

---31.96M

-2023.44%-37.33M

54.89%-15.79M

103.19%1.94M

11.57%-53.82M

37.28%-35.00M

-18.48%-62.16M

-33.18%-60.93M

---60.86M

---55.81M

-55.01%-52.47M

-41.70%-45.75M

---33.85M

---32.28M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did ADC Therapeutics SA Generate?



ADC Therapeutics SA generated -141.17M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did ADC Therapeutics SA's Operating Cash Flow Change Year Over Year?



ADC Therapeutics SA's operating cash flow increased by -14.00% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does ADC Therapeutics SA Spend on Capital Expenditures?



ADC Therapeutics SA spent 264.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has ADC Therapeutics SA's Financing Cash Flow Changed?



ADC Therapeutics SA used 150.94M in financing activities in the latest quarter.

What is free cash flow and why does it matter for ADCT?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was ADC Therapeutics SA’s free cash flow in the latest quarter?



Free cash flow was -141.44M reflecting a -13.42% change from the previous year.